Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and the resulting disease, coronavirus disease 2019 (Covid-19), have spread to millions of persons worldwide. Multiple vaccine candidates are under development, but no vaccine is currently available. Interim safety a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:N Engl J Med
Autors principals: Walsh, Edward E., Frenck, Robert W., Falsey, Ann R., Kitchin, Nicholas, Absalon, Judith, Gurtman, Alejandra, Lockhart, Stephen, Neuzil, Kathleen, Mulligan, Mark J., Bailey, Ruth, Swanson, Kena A., Li, Ping, Koury, Kenneth, Kalina, Warren, Cooper, David, Fontes-Garfias, Camila, Shi, Pei-Yong, Türeci, Özlem, Tompkins, Kristin R., Lyke, Kirsten E., Raabe, Vanessa, Dormitzer, Philip R., Jansen, Kathrin U., Şahin, Uğur, Gruber, William C.
Format: Artigo
Idioma:Inglês
Publicat: Massachusetts Medical Society 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7583697/
https://ncbi.nlm.nih.gov/pubmed/33053279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2027906
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars